As of Jun 29
| -0.20 / -2.14%|
The 1 analysts offering 12-month price forecasts for SciClone Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a -12.66% decrease from the last price of 9.16.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.